Biomarkers in cancer staging, prognosis and treatment selection
JA Ludwig, JN Weinstein - Nature Reviews Cancer, 2005 - nature.com
Advances in genomics, proteomics and molecular pathology have generated many
candidate biomarkers with potential clinical value. Their use for cancer staging and …
candidate biomarkers with potential clinical value. Their use for cancer staging and …
MicroRNA-34a: a potential therapeutic target in human cancer
XJ Li, ZJ Ren, JH Tang - Cell death & disease, 2014 - nature.com
MicroRNAs (miRs) are small noncoding RNAs that negatively regulate gene expression by
binding to the three untranslated regions of their target mRNAs. Deregulations of miRs were …
binding to the three untranslated regions of their target mRNAs. Deregulations of miRs were …
[HTML][HTML] 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment
R Guerrero-Preston, F Godoy-Vitorino, A Jedlicka… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Systemic inflammatory events and localized disease, mediated by the microbiome, may be
measured in saliva as head and neck squamous cell carcinoma (HNSCC) diagnostic and …
measured in saliva as head and neck squamous cell carcinoma (HNSCC) diagnostic and …
Bladder cancer in 2010: how far have we come?
BL Jacobs, CT Lee, JE Montie - CA: a cancer journal for …, 2010 - Wiley Online Library
Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from
cancer among men in the United States. Although guidelines assist in treatment, the art of …
cancer among men in the United States. Although guidelines assist in treatment, the art of …
An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays
Abstract Changes in DNA copy number contribute to cancer pathogenesis. We now show
that high-density single nucleotide polymorphism (SNP) arrays can detect copy number …
that high-density single nucleotide polymorphism (SNP) arrays can detect copy number …
DNA microarrays: a powerful genomic tool for biomedical and clinical research
V Trevino, F Falciani, HA Barrera-Saldaña - Molecular medicine, 2007 - Springer
Among the many benefits of the Human Genome Project are new and powerful tools such as
the genome-wide hybridization devices referred to as microarrays. Initially designed to …
the genome-wide hybridization devices referred to as microarrays. Initially designed to …
[HTML][HTML] Molecular classification of rhabdomyosarcoma—genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group
E Davicioni, MJ Anderson, FG Finckenstein… - The American journal of …, 2009 - Elsevier
Rhabdomyosarcoma (RMS) in children occurs as two major histological subtypes,
embryonal (ERMS) and alveolar (ARMS). ERMS is associated with an 11p15. 5 loss of …
embryonal (ERMS) and alveolar (ARMS). ERMS is associated with an 11p15. 5 loss of …
Endometriosis and the neoplastic process
Endometriosis is a frequent disorder that commonly presents with infertility and pelvic pain.
Although the precise aetiology of endometriosis is unclear, it is generally considered to …
Although the precise aetiology of endometriosis is unclear, it is generally considered to …
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
MA Knowles - Carcinogenesis, 2006 - academic.oup.com
Cancer of the bladder shows divergent clinical behaviour following diagnosis and it has
been proposed that two major groups of tumours exist that develop via different molecular …
been proposed that two major groups of tumours exist that develop via different molecular …
Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection
Background: The noninvasive identification of bladder tumors may improve disease control
and prevent disease progression. Aberrant promoter methylation (ie, hypermethylation) is a …
and prevent disease progression. Aberrant promoter methylation (ie, hypermethylation) is a …